메뉴 건너뛰기




Volumn 8, Issue 10, 2007, Pages 805-813

Targeting protein tyrosine phosphatase to enhance insulin action for the potential treatment of diabetes

Author keywords

Insulin resistance; Leptin sensitivity; Protein tyrosine phosphatase; Type 2 diabetes

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BENZOFURAN DERIVATIVE; BIS(MALTOLATO)OXOVANADIUM; INSULIN; ISIS 113715; JTT 551; LEPTIN; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR; STIBOGLUCONATE SODIUM; TRODUSQUEMINE; UNCLASSIFIED DRUG; VANADIUM DERIVATIVE; VDQ 001; WO 03048140;

EID: 34848875071     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (38)

References (85)
  • 2
    • 2342466734 scopus 로고    scopus 로고
    • Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030
    • Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 27(5):1047-1053.
    • (2004) Diabetes Care , vol.27 , Issue.5 , pp. 1047-1053
    • Wild, S.1    Roglic, G.2    Green, A.3    Sicree, R.4    King, H.5
  • 3
    • 33845881411 scopus 로고    scopus 로고
    • Kahn SE, Hull RL, Utzschneider KM: Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature (2006) 444(7121):840-846. • Molecular mechanisms linking obesity to development of insulin resistance are described in this review with specific reference to β-cell failure.
    • Kahn SE, Hull RL, Utzschneider KM: Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature (2006) 444(7121):840-846. • Molecular mechanisms linking obesity to development of insulin resistance are described in this review with specific reference to β-cell failure.
  • 4
    • 0037219294 scopus 로고    scopus 로고
    • The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intraabdominal fat
    • Nieves DJ, Cnop M, Retzlaff B, Walden CE, Brunzell JD, Knopp RH, Kahn SE: The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intraabdominal fat. Diabetes (2003) 52(1):172-179.
    • (2003) Diabetes , vol.52 , Issue.1 , pp. 172-179
    • Nieves, D.J.1    Cnop, M.2    Retzlaff, B.3    Walden, C.E.4    Brunzell, J.D.5    Knopp, R.H.6    Kahn, S.E.7
  • 6
    • 34247577093 scopus 로고    scopus 로고
    • The DREAM Trial: Using ramipril and rosiglitazone to prevent diabetes
    • Shah V, Pratley RE: The DREAM Trial: Using ramipril and rosiglitazone to prevent diabetes. Curr Diab Rep (2007) 7(1):53-55.
    • (2007) Curr Diab Rep , vol.7 , Issue.1 , pp. 53-55
    • Shah, V.1    Pratley, R.E.2
  • 8
    • 0033525870 scopus 로고    scopus 로고
    • Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, Ramachandran C et al: Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science (1999) 283(5407):1544-1548. •• This is an important pivotal study that demonstrated the role of PTP1B in insulin resistance and obesity using gene knockout technology. This knockout phenotype generated much interest in PTP1B as a drug target for type 2 diabetes.
    • Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, Ramachandran C et al: Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science (1999) 283(5407):1544-1548. •• This is an important pivotal study that demonstrated the role of PTP1B in insulin resistance and obesity using gene knockout technology. This knockout phenotype generated much interest in PTP1B as a drug target for type 2 diabetes.
  • 9
    • 21244444303 scopus 로고    scopus 로고
    • Bialy L, Waldmann H: Inhibitors of protein tyrosine phosphatases: Next-generation drugs? Angew Chem Int Ed Engl (2005) 44(25):3814-3839. •• This review describes in detail various strategies that were applied in the development of small-molecule inhibitors of PTPs, by both academic research groups and biotechnology companies.
    • Bialy L, Waldmann H: Inhibitors of protein tyrosine phosphatases: Next-generation drugs? Angew Chem Int Ed Engl (2005) 44(25):3814-3839. •• This review describes in detail various strategies that were applied in the development of small-molecule inhibitors of PTPs, by both academic research groups and biotechnology companies.
  • 12
    • 0033942614 scopus 로고    scopus 로고
    • Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH, Stricker-Krongrad A et al: Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol (2000) 20(15):5479-5489. •• This is an important study that demonstrated the role of PTP1B in the regulation of metabolism. Mice lacking this enzyme are insulin sensitive and are resistant to diet-induced obesity.
    • Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH, Stricker-Krongrad A et al: Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol (2000) 20(15):5479-5489. •• This is an important study that demonstrated the role of PTP1B in the regulation of metabolism. Mice lacking this enzyme are insulin sensitive and are resistant to diet-induced obesity.
  • 13
    • 2642541849 scopus 로고    scopus 로고
    • Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action
    • Zabolotny JM, Haj FG, Kim YB, Kim HJ, Shulman GI, Kim JK, Neel BG, Kahn BB: Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action. J Biol Chem (2004) 279(23):24844-24851.
    • (2004) J Biol Chem , vol.279 , Issue.23 , pp. 24844-24851
    • Zabolotny, J.M.1    Haj, F.G.2    Kim, Y.B.3    Kim, H.J.4    Shulman, G.I.5    Kim, J.K.6    Neel, B.G.7    Kahn, B.B.8
  • 14
    • 33847060409 scopus 로고    scopus 로고
    • Protein-tyrosine phosphatase 1B-deficient myocytes show increased insulin sensitivity and protection against tumor necrosis factor-α-induced insulin resistance
    • Nieto-Vazquez I, Fernández-Veledo S, de Alvaro C, Rondinone CM, Valverde AM, Lorenzo M: Protein-tyrosine phosphatase 1B-deficient myocytes show increased insulin sensitivity and protection against tumor necrosis factor-α-induced insulin resistance. Diabetes (2007) 56(2):404-413.
    • (2007) Diabetes , vol.56 , Issue.2 , pp. 404-413
    • Nieto-Vazquez, I.1    Fernández-Veledo, S.2    de Alvaro, C.3    Rondinone, C.M.4    Valverde, A.M.5    Lorenzo, M.6
  • 17
    • 0037143754 scopus 로고    scopus 로고
    • Zinker BA, Rondinone CM, Trevillyan JM, Gum RJ, Clampit JE, Waring JF, Xie N, Wilcox D, Jacobson P, Frost L, Kroeger PE et al: PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. Proc Natl Acad Sci USA (2002) 99(17):11357-11362. • This report further validates PTP1B as a drug target. ISIS was the first pharmaceutical company that reported the development of PTP1B ASOs and its use in a mouse model of diabetes in vivo. ISIS-113715, a second generation ASO, is currently undergoing phase II clinical trials.
    • Zinker BA, Rondinone CM, Trevillyan JM, Gum RJ, Clampit JE, Waring JF, Xie N, Wilcox D, Jacobson P, Frost L, Kroeger PE et al: PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. Proc Natl Acad Sci USA (2002) 99(17):11357-11362. • This report further validates PTP1B as a drug target. ISIS was the first pharmaceutical company that reported the development of PTP1B ASOs and its use in a mouse model of diabetes in vivo. ISIS-113715, a second generation ASO, is currently undergoing phase II clinical trials.
  • 19
    • 33846548680 scopus 로고    scopus 로고
    • Developmental switch from prolonged insulin action to increased insulin sensitivity in protein tyrosine phosphatase 1B-deficient hepatocytes
    • Gonzalez-Rodriguez A, Clampit JE, Escribano O, Benito M, Rondinone CM, Valverde AM: Developmental switch from prolonged insulin action to increased insulin sensitivity in protein tyrosine phosphatase 1B-deficient hepatocytes. Endocrinology (2007) 148(2):594-608.
    • (2007) Endocrinology , vol.148 , Issue.2 , pp. 594-608
    • Gonzalez-Rodriguez, A.1    Clampit, J.E.2    Escribano, O.3    Benito, M.4    Rondinone, C.M.5    Valverde, A.M.6
  • 20
    • 0347990604 scopus 로고    scopus 로고
    • Islet-sparing effects of protein tyrosine phosphatase-1b deficiency delays onset of diabetes in IRS2 knockout mice
    • Kushner JA, Haj FG, Klaman LD, Dow MA, Kahn BB, Neel BG, White MF: Islet-sparing effects of protein tyrosine phosphatase-1b deficiency delays onset of diabetes in IRS2 knockout mice. Diabetes (2004) 53(1):61-66.
    • (2004) Diabetes , vol.53 , Issue.1 , pp. 61-66
    • Kushner, J.A.1    Haj, F.G.2    Klaman, L.D.3    Dow, M.A.4    Kahn, B.B.5    Neel, B.G.6    White, M.F.7
  • 22
    • 14344255690 scopus 로고    scopus 로고
    • Winter CL, Lange JS, Davis MG, Gerwe GS, Downs TR, Peters KG, Kasibhatla B: A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato)oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats. Exp Biol Med (2005) 230(3):207-216. • This paper describes the use of a small-molecular weight compound that is an inhibitor of PTP1B in improving insulin sensitivity and preventing type 2 diabetes in Zucker diabetic fatty rats.
    • Winter CL, Lange JS, Davis MG, Gerwe GS, Downs TR, Peters KG, Kasibhatla B: A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato)oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats. Exp Biol Med (2005) 230(3):207-216. • This paper describes the use of a small-molecular weight compound that is an inhibitor of PTP1B in improving insulin sensitivity and preventing type 2 diabetes in Zucker diabetic fatty rats.
  • 24
    • 33845391536 scopus 로고    scopus 로고
    • Vercauteren M, Remy E, Devaux C, Dautreaux B, Henry JP, Bauer F, Mulder P, van Huijsduijnen RH, Bombrun A, Thuillez C, Richard V: Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure. Circulation (2006) 114(23):2498-2507. • Endothelial dysfunction is characterized by a decrease in nitric oxide (NO) production. PTP1B inhibition stimulates early eNOS phosphorylation and subsequent activation of NO synthase, thus, providing evidence that PTP1B plays a role in endothelial function. The results presented demonstrated for the first time that PTP1B inhibitors may be useful in the potential treatment of endothelial dysfunction.
    • Vercauteren M, Remy E, Devaux C, Dautreaux B, Henry JP, Bauer F, Mulder P, van Huijsduijnen RH, Bombrun A, Thuillez C, Richard V: Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure. Circulation (2006) 114(23):2498-2507. • Endothelial dysfunction is characterized by a decrease in nitric oxide (NO) production. PTP1B inhibition stimulates early eNOS phosphorylation and subsequent activation of NO synthase, thus, providing evidence that PTP1B plays a role in endothelial function. The results presented demonstrated for the first time that PTP1B inhibitors may be useful in the potential treatment of endothelial dysfunction.
  • 25
    • 0037205740 scopus 로고    scopus 로고
    • An attempt to promote neo-vascularization by employing a newly synthesized inhibitor of protein tyrosine phosphatase
    • Soeda S, Shimada T, Koyanagi S, Yokomatsu T, Murano T, Shibuya S, Shimeno H: An attempt to promote neo-vascularization by employing a newly synthesized inhibitor of protein tyrosine phosphatase. FEBS Lett (2002) 524(1-3):54-58.
    • (2002) FEBS Lett , vol.524 , Issue.1-3 , pp. 54-58
    • Soeda, S.1    Shimada, T.2    Koyanagi, S.3    Yokomatsu, T.4    Murano, T.5    Shibuya, S.6    Shimeno, H.7
  • 29
    • 33745975185 scopus 로고    scopus 로고
    • Genetic susceptibility contributes to renal and cardiovascular complications of type 2 diabetes mellitus
    • Freedman BI, Bowden DW, Sale MM, Langefeld CD, Rich SS: Genetic susceptibility contributes to renal and cardiovascular complications of type 2 diabetes mellitus. Hypertension (2006) 48(1):8-13.
    • (2006) Hypertension , vol.48 , Issue.1 , pp. 8-13
    • Freedman, B.I.1    Bowden, D.W.2    Sale, M.M.3    Langefeld, C.D.4    Rich, S.S.5
  • 30
    • 0032558725 scopus 로고    scopus 로고
    • Leptin and the regulation of body weight in mammals
    • Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature (1998) 395(6704):763-770.
    • (1998) Nature , vol.395 , Issue.6704 , pp. 763-770
    • Friedman, J.M.1    Halaas, J.L.2
  • 31
    • 4344644432 scopus 로고    scopus 로고
    • Body fat, leptin, and hypothalamic amenorrhea
    • Ahima RS: Body fat, leptin, and hypothalamic amenorrhea. N Engl J Med (2004) 351(10):959-962.
    • (2004) N Engl J Med , vol.351 , Issue.10 , pp. 959-962
    • Ahima, R.S.1
  • 32
    • 2442670123 scopus 로고    scopus 로고
    • Leptin signaling
    • Ahima RS, Osei SY: Leptin signaling. Physiol Behav (2004) 81(2):223-241.
    • (2004) Physiol Behav , vol.81 , Issue.2 , pp. 223-241
    • Ahima, R.S.1    Osei, S.Y.2
  • 35
    • 0037297088 scopus 로고    scopus 로고
    • Leptin resistance - or why leptin fails to work in obesity
    • El-Haschimi K, Lehnert H: Leptin resistance - or why leptin fails to work in obesity. Exp Clin Endocrinol Diabetes (2003) 111(1):2-7.
    • (2003) Exp Clin Endocrinol Diabetes , vol.111 , Issue.1 , pp. 2-7
    • El-Haschimi, K.1    Lehnert, H.2
  • 36
    • 18344379861 scopus 로고    scopus 로고
    • Zabolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, Haj F, Wang Y, Minokoshi Y, Kim YB, Elmquist JK, Tartaglia LA, Kahn BB, Neel BG: PTP1B regulates leptin signal transduction in vivo. Dev Cell (2002) 2(4):489-495. •• This paper and reference [37 ••] describes the potential crosstalk between leptin and insulin signaling and Jak/STAT proteins via PTP1B.
    • Zabolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, Haj F, Wang Y, Minokoshi Y, Kim YB, Elmquist JK, Tartaglia LA, Kahn BB, Neel BG: PTP1B regulates leptin signal transduction in vivo. Dev Cell (2002) 2(4):489-495. •• This paper and reference [37 ••] describes the potential crosstalk between leptin and insulin signaling and Jak/STAT proteins via PTP1B.
  • 37
    • 0036228770 scopus 로고    scopus 로고
    • Cheng A, Uetani N, Simoncic PD, Chaubey VP, Lee-Loy A, McGlade CJ, Kennedy BP, Tremblay ML: Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev Cell (2002) 2(4):497-503. •• This paper and reference [36 ••] describes the potential crosstalk between leptin and insulin signaling and Jak/STAT proteins via PTP1B.
    • Cheng A, Uetani N, Simoncic PD, Chaubey VP, Lee-Loy A, McGlade CJ, Kennedy BP, Tremblay ML: Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev Cell (2002) 2(4):497-503. •• This paper and reference [36 ••] describes the potential crosstalk between leptin and insulin signaling and Jak/STAT proteins via PTP1B.
  • 38
    • 17844410359 scopus 로고    scopus 로고
    • Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling
    • Lund IK, Hansen JA, Andersen HS, Møller NP, Billestrup N: Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling. J Mol Endocrinol (2005) 34(2):339-351.
    • (2005) J Mol Endocrinol , vol.34 , Issue.2 , pp. 339-351
    • Lund, I.K.1    Hansen, J.A.2    Andersen, H.S.3    Møller, N.P.4    Billestrup, N.5
  • 39
    • 33746810001 scopus 로고    scopus 로고
    • Bence KK, Delibegovic M, Xue B, Gorgun CZ, Hotamisligil GS, Neel BG, Kahn BB: Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat Med (2006) 12(8):917-924. •• This paper describes tissue-specific PTP1B knockout mice and the phenotype. Neuronal knockout mice are characterized by reduced weight and adiposity, and energy expenditure in contrast to adipose muscle or liver tissue knockouts. These mice are hypersensitive to leptin, and show improved glucose homeostasis, demonstrating that PTP1B regulates body mass and adiposity primarily through its actions in the brain.
    • Bence KK, Delibegovic M, Xue B, Gorgun CZ, Hotamisligil GS, Neel BG, Kahn BB: Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat Med (2006) 12(8):917-924. •• This paper describes tissue-specific PTP1B knockout mice and the phenotype. Neuronal knockout mice are characterized by reduced weight and adiposity, and energy expenditure in contrast to adipose muscle or liver tissue knockouts. These mice are hypersensitive to leptin, and show improved glucose homeostasis, demonstrating that PTP1B regulates body mass and adiposity primarily through its actions in the brain.
  • 50
    • 11844295386 scopus 로고    scopus 로고
    • Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP
    • Galic S, Hauser C, Kahn BB, Haj FG, Neel BG, Tonks NK, Tiganis T: Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP. Mol Cell Biol (2005) 25(2):819-829.
    • (2005) Mol Cell Biol , vol.25 , Issue.2 , pp. 819-829
    • Galic, S.1    Hauser, C.2    Kahn, B.B.3    Haj, F.G.4    Neel, B.G.5    Tonks, N.K.6    Tiganis, T.7
  • 51
    • 29144492209 scopus 로고    scopus 로고
    • Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases: From diabetes, obesity to cell cycle, and cancer
    • Dubé N, Tremblay ML: Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases: From diabetes, obesity to cell cycle, and cancer. Biochim Biophys Acta (2005) 1754(1-2):108-117.
    • (2005) Biochim Biophys Acta , vol.1754 , Issue.1-2 , pp. 108-117
    • Dubé, N.1    Tremblay, M.L.2
  • 52
    • 34248334251 scopus 로고    scopus 로고
    • TC-PTP-deficient bone marrow stromal cells fail to support normal B lymphopoiesis due to abnormal secretion of interferon-γ
    • Bourdeau A, Dubé N, Heinonen KM, Théberge JF, Doody KM, Tremblay ML: TC-PTP-deficient bone marrow stromal cells fail to support normal B lymphopoiesis due to abnormal secretion of interferon-γ. Blood (2007) 109(10):4220-4228.
    • (2007) Blood , vol.109 , Issue.10 , pp. 4220-4228
    • Bourdeau, A.1    Dubé, N.2    Heinonen, K.M.3    Théberge, J.F.4    Doody, K.M.5    Tremblay, M.L.6
  • 53
    • 15044343929 scopus 로고    scopus 로고
    • Cytoplasmic protein tyrosine phosphatases, regulation and function: The roles of PTP1B and TC-PTP
    • Bourdeau A, Dubé N, Tremblay ML: Cytoplasmic protein tyrosine phosphatases, regulation and function: The roles of PTP1B and TC-PTP. Curr Opin Cell Biol (2005) 17(2):203-209.
    • (2005) Curr Opin Cell Biol , vol.17 , Issue.2 , pp. 203-209
    • Bourdeau, A.1    Dubé, N.2    Tremblay, M.L.3
  • 54
    • 0030769147 scopus 로고    scopus 로고
    • Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice
    • You-Ten KE, Muise ES, Itié A, Michaliszyn E, Wagner J, Jothy S, Lapp WS, Tremblay ML: Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice. J Exp Med (1997) 186(5):683-693.
    • (1997) J Exp Med , vol.186 , Issue.5 , pp. 683-693
    • You-Ten, K.E.1    Muise, E.S.2    Itié, A.3    Michaliszyn, E.4    Wagner, J.5    Jothy, S.6    Lapp, W.S.7    Tremblay, M.L.8
  • 55
    • 33847202286 scopus 로고    scopus 로고
    • Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis
    • Julien SG, Dubé N, Read M, Penney J, Paquet M, Han Y, Kennedy BP, Muller WJ, Tremblay ML: Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis. Nat Genet (2007) 39(3):338-346.
    • (2007) Nat Genet , vol.39 , Issue.3 , pp. 338-346
    • Julien, S.G.1    Dubé, N.2    Read, M.3    Penney, J.4    Paquet, M.5    Han, Y.6    Kennedy, B.P.7    Muller, W.J.8    Tremblay, M.L.9
  • 56
    • 4644350462 scopus 로고    scopus 로고
    • Dubé N, Tremblay ML: Beyond the metabolic function of PTP1B. Cell Cycle (2004) 3(5):550-553. • This review discusses the role of PTP1B beyond metabolic diseases. PTP1B plays a positive and negative role in the regulation of oncogenesis by modulating signaling via the Ras pathway, a key regulatory signaling molecule in cellular transformation.
    • Dubé N, Tremblay ML: Beyond the metabolic function of PTP1B. Cell Cycle (2004) 3(5):550-553. • This review discusses the role of PTP1B beyond metabolic diseases. PTP1B plays a positive and negative role in the regulation of oncogenesis by modulating signaling via the Ras pathway, a key regulatory signaling molecule in cellular transformation.
  • 57
    • 33847375227 scopus 로고    scopus 로고
    • Protein-tyrosine phosphatase 1B is required for HER2/neu-induced breast cancer
    • Bentires-Alj M, Neel BG: Protein-tyrosine phosphatase 1B is required for HER2/neu-induced breast cancer. Cancer Res (2007) 67(6):2420-2424.
    • (2007) Cancer Res , vol.67 , Issue.6 , pp. 2420-2424
    • Bentires-Alj, M.1    Neel, B.G.2
  • 58
    • 1242296879 scopus 로고    scopus 로고
    • The role of protein tyrosine phosphatase 1B in Ras signaling
    • Dubé N, Cheng A, Tremblay ML: The role of protein tyrosine phosphatase 1B in Ras signaling. Proc Natl Acad Sci USA (2004) 101(7):1834-1839.
    • (2004) Proc Natl Acad Sci USA , vol.101 , Issue.7 , pp. 1834-1839
    • Dubé, N.1    Cheng, A.2    Tremblay, M.L.3
  • 59
    • 33847391938 scopus 로고    scopus 로고
    • A brake becomes an accelerator: PTP1B - a new therapeutic target for breast cancer
    • Tonks NK, Muthuswamy SK: A brake becomes an accelerator: PTP1B - a new therapeutic target for breast cancer. Cancer Cell (2007) 11(3):214-216.
    • (2007) Cancer Cell , vol.11 , Issue.3 , pp. 214-216
    • Tonks, N.K.1    Muthuswamy, S.K.2
  • 60
    • 0028327324 scopus 로고
    • Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: Association with p185c-erbB-2 protein expression
    • Wiener JR, Kerns BJ, Harvey EL, Conaway MR, Iglehart JD, Berchuck A, Bast RC Jr: Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: Association with p185c-erbB-2 protein expression. J Natl Cancer Inst (1994) 86(5):372-378.
    • (1994) J Natl Cancer Inst , vol.86 , Issue.5 , pp. 372-378
    • Wiener, J.R.1    Kerns, B.J.2    Harvey, E.L.3    Conaway, M.R.4    Iglehart, J.D.5    Berchuck, A.6    Bast Jr, R.C.7
  • 61
    • 0034731372 scopus 로고    scopus 로고
    • Identification of protein-tyrosine phosphatase 1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines
    • Bjorge JD, Pang A, Fujita DJ: Identification of protein-tyrosine phosphatase 1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines. J Biol Chem (2000) 275(52):41439-41446.
    • (2000) J Biol Chem , vol.275 , Issue.52 , pp. 41439-41446
    • Bjorge, J.D.1    Pang, A.2    Fujita, D.J.3
  • 62
    • 22144493870 scopus 로고    scopus 로고
    • EGF receptor-ligand interaction generates extracellular hydrogen peroxide that inhibits EGFR-associated protein tyrosine phosphatases
    • DeYulia GJ Jr, Cárcamo JM: EGF receptor-ligand interaction generates extracellular hydrogen peroxide that inhibits EGFR-associated protein tyrosine phosphatases. Biochem Biophys Res Commun (2005) 334(1):38-42.
    • (2005) Biochem Biophys Res Commun , vol.334 , Issue.1 , pp. 38-42
    • DeYulia Jr, G.J.1    Cárcamo, J.M.2
  • 63
    • 0042734919 scopus 로고    scopus 로고
    • Reactive oxygen species as mediators of cell adhesion
    • Chiarugi P: Reactive oxygen species as mediators of cell adhesion. Ital J Biochem (2003) 52(1):28-32.
    • (2003) Ital J Biochem , vol.52 , Issue.1 , pp. 28-32
    • Chiarugi, P.1
  • 65
    • 33947174540 scopus 로고    scopus 로고
    • Isis Pharmaceuticals Inc: Isis Pharmaceuticals and Symphony GenIsis enter into $75 million product development collaboration, April 07
    • Isis Pharmaceuticals Inc: Isis Pharmaceuticals and Symphony GenIsis enter into $75 million product development collaboration. Press Release (2006): April 07.
    • (2006) Press Release
  • 66
    • 34848922479 scopus 로고    scopus 로고
    • ISIS 113715 improves glucose control in patients with type 2 diabetes
    • Isis Pharmaceuticals Inc: Isis Pharmaceuticals reports positive phase 2 data:, June 13
    • Isis Pharmaceuticals Inc: Isis Pharmaceuticals reports positive phase 2 data: ISIS 113715 improves glucose control in patients with type 2 diabetes. Press Release (2006): June 13.
    • (2006) Press Release
  • 67
    • 34848921222 scopus 로고    scopus 로고
    • Early preclinical research shows ability to silence PTP-1B expression
    • Sirna Therapeutics Inc: Sirna Therapeutics launches program to treat diabetes with RNAi technology:, January 06
    • Sirna Therapeutics Inc: Sirna Therapeutics launches program to treat diabetes with RNAi technology: Early preclinical research shows ability to silence PTP-1B expression. Press Release (2005): January 06.
    • (2005) Press Release
  • 68
    • 20444381342 scopus 로고    scopus 로고
    • VioQuest Pharmaceuticals Inc: Tropical disease leads to treatment for cancer, August 18
    • VioQuest Pharmaceuticals Inc: Tropical disease leads to treatment for cancer. Press Release (2005): August 18.
    • (2005) Press Release
  • 69
    • 34848820960 scopus 로고    scopus 로고
    • New drugs in the R&D pipeline. Pharma Jpn (2006) 2021:9.
    • New drugs in the R&D pipeline. Pharma Jpn (2006) 2021:9.
  • 70
    • 0028077830 scopus 로고
    • Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp
    • Burke TR Jr, Kole HK, Roller PP: Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp. Biochem Biophys Res Commun (1994) 204(1):129-134.
    • (1994) Biochem Biophys Res Commun , vol.204 , Issue.1 , pp. 129-134
    • Burke Jr, T.R.1    Kole, H.K.2    Roller, P.P.3
  • 71
    • 0028785789 scopus 로고
    • Why is phosphonodifluoromethyl phenylalanine a more potent inhibitory moiety than phosphonomethyl phenylalanine toward protein-tyrosine phosphatases?
    • Chen L, Wu L, Otaka A, Smyth MS, Roller PP, Burke TR Jr, den Hertog J, Zhang ZY: Why is phosphonodifluoromethyl phenylalanine a more potent inhibitory moiety than phosphonomethyl phenylalanine toward protein-tyrosine phosphatases? Biochem Biophys Res Commun (1995) 216(3):976- 984.
    • (1995) Biochem Biophys Res Commun , vol.216 , Issue.3 , pp. 976-984
    • Chen, L.1    Wu, L.2    Otaka, A.3    Smyth, M.S.4    Roller, P.P.5    Burke Jr, T.R.6    den Hertog, J.7    Zhang, Z.Y.8
  • 73
    • 32044449378 scopus 로고    scopus 로고
    • Klopfenstein SR, Evdokimov AG, Colson AO, Fairweather NT, Neuman JJ, Maier MB, Gray JL, Gerwe GS, Stake GE, Howard BW, Farmer JA et al: 1,2,3,4-Tetrahydroisoquinolinyl sulfamic acids as phosphatase PTP1B inhibitors. Bioorg Med Chem Lett (2006) 16(6):1574-1578.
    • Klopfenstein SR, Evdokimov AG, Colson AO, Fairweather NT, Neuman JJ, Maier MB, Gray JL, Gerwe GS, Stake GE, Howard BW, Farmer JA et al: 1,2,3,4-Tetrahydroisoquinolinyl sulfamic acids as phosphatase PTP1B inhibitors. Bioorg Med Chem Lett (2006) 16(6):1574-1578.
  • 74
    • 0031457541 scopus 로고    scopus 로고
    • Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: A paradigm for inhibitor design
    • Puius YA, Zhao Y, Sullivan M, Lawrence DS, Almo SC, Zhang ZY: Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: A paradigm for inhibitor design. Proc Natl Acad Sci USA (1997) 94(25):13420-13425.
    • (1997) Proc Natl Acad Sci USA , vol.94 , Issue.25 , pp. 13420-13425
    • Puius, Y.A.1    Zhao, Y.2    Sullivan, M.3    Lawrence, D.S.4    Almo, S.C.5    Zhang, Z.Y.6
  • 75
    • 0035861668 scopus 로고    scopus 로고
    • Shen K, Keng YF, Wu L, Guo XL, Lawrence DS, Zhang ZY: Acquisition of a specific and potent PTP1B inhibitor from a novel combinatorial library and screening procedure. J Biol Chem (2001) 276(50):47311-47319. •This paper describes the identification of potent and novel PTP1B inhibitors using a combinatorial chemistry approach to rapidly delineate scaffolds for further permeability optimization.
    • Shen K, Keng YF, Wu L, Guo XL, Lawrence DS, Zhang ZY: Acquisition of a specific and potent PTP1B inhibitor from a novel combinatorial library and screening procedure. J Biol Chem (2001) 276(50):47311-47319. •This paper describes the identification of potent and novel PTP1B inhibitors using a combinatorial chemistry approach to rapidly delineate scaffolds for further permeability optimization.
  • 77
    • 33846916227 scopus 로고    scopus 로고
    • Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives
    • Stuible M, Zhao L, Aubry I, Schmidt-Arras D, Böhmer FD, Li CJ, Tremblay ML: Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives. Chembiochem (2007) 8(2):179-186.
    • (2007) Chembiochem , vol.8 , Issue.2 , pp. 179-186
    • Stuible, M.1    Zhao, L.2    Aubry, I.3    Schmidt-Arras, D.4    Böhmer, F.D.5    Li, C.J.6    Tremblay, M.L.7
  • 78
    • 3543017313 scopus 로고    scopus 로고
    • Wiesmann C, Barr KJ, Kung J, Zhu J, Erlanson DA, Shen W, Fahr BJ, Zhong M, Taylor L, Randal M, McDowell RS, Hansen SK: Allosteric inhibition of protein tyrosine phosphatase 1B. Nat Struct Mol Biol (2004) 11(8):730-737. •• This paper discloses the inhibitory activity, binding pocket and co-crystalization of benzofuran molecules in a non-catalytic binding site of PTP1B, thus providing evidence for the potential use of more cell permeable scaffolds for inhibition of the phosphatase.
    • Wiesmann C, Barr KJ, Kung J, Zhu J, Erlanson DA, Shen W, Fahr BJ, Zhong M, Taylor L, Randal M, McDowell RS, Hansen SK: Allosteric inhibition of protein tyrosine phosphatase 1B. Nat Struct Mol Biol (2004) 11(8):730-737. •• This paper discloses the inhibitory activity, binding pocket and co-crystalization of benzofuran molecules in a non-catalytic binding site of PTP1B, thus providing evidence for the potential use of more cell permeable scaffolds for inhibition of the phosphatase.
  • 79
    • 19644378636 scopus 로고    scopus 로고
    • Allosteric inhibition of PTP1B activity by selective modification of a non-active site cysteine residue
    • Hansen SK, Cancilla MT, Shiau TP, Kung J, Chen T, Erlanson DA: Allosteric inhibition of PTP1B activity by selective modification of a non-active site cysteine residue. Biochemistry (2005) 44(21):7704-7712.
    • (2005) Biochemistry , vol.44 , Issue.21 , pp. 7704-7712
    • Hansen, S.K.1    Cancilla, M.T.2    Shiau, T.P.3    Kung, J.4    Chen, T.5    Erlanson, D.A.6
  • 80
    • 33646196499 scopus 로고    scopus 로고
    • Residues distant from the active site influence protein-tyrosine phosphatase 1B inhibitor binding
    • Montalibet J, Skorey K, McKay D, Scapin G, Asante-Appiah E, Kennedy BP: Residues distant from the active site influence protein-tyrosine phosphatase 1B inhibitor binding. J Biol Chem (2006) 281(8):5258-5266.
    • (2006) J Biol Chem , vol.281 , Issue.8 , pp. 5258-5266
    • Montalibet, J.1    Skorey, K.2    McKay, D.3    Scapin, G.4    Asante-Appiah, E.5    Kennedy, B.P.6
  • 81
    • 33646828668 scopus 로고    scopus 로고
    • A targeted molecular dynamics study of WPD loop movement in PTP1B
    • Kamerlin SC, Rucker R, Boresch S: A targeted molecular dynamics study of WPD loop movement in PTP1B. Biochem Biophys Res Commun (2006) 345(3):1161-1166.
    • (2006) Biochem Biophys Res Commun , vol.345 , Issue.3 , pp. 1161-1166
    • Kamerlin, S.C.1    Rucker, R.2    Boresch, S.3
  • 82
    • 33847383241 scopus 로고    scopus 로고
    • Synthesis and cell-based activity of a potent and selective protein tyrosine phosphatase 1B inhibitor prodrug
    • Boutselis IG, Yu X, Zhang ZY, Borch RF: Synthesis and cell-based activity of a potent and selective protein tyrosine phosphatase 1B inhibitor prodrug. J Med Chem (2007) 50(4):856-864.
    • (2007) J Med Chem , vol.50 , Issue.4 , pp. 856-864
    • Boutselis, I.G.1    Yu, X.2    Zhang, Z.Y.3    Borch, R.F.4
  • 83
    • 33744786265 scopus 로고    scopus 로고
    • Design and synthesis of phosphotyrosine peptidomimetic prodrugs
    • Garrido-Hernandez H, Moon KD, Geahlen RL, Borch RF: Design and synthesis of phosphotyrosine peptidomimetic prodrugs. J Med Chem (2006) 49(11):3368-3376.
    • (2006) J Med Chem , vol.49 , Issue.11 , pp. 3368-3376
    • Garrido-Hernandez, H.1    Moon, K.D.2    Geahlen, R.L.3    Borch, R.F.4
  • 85
    • 34848830179 scopus 로고    scopus 로고
    • JAPAN TOBACCO INC (Inaba T, Ikemoto T, Sakata S, Maegawa H, Kashiwagi A): Azole compounds and medicinal use thereof. WO-03048140 (2003).
    • JAPAN TOBACCO INC (Inaba T, Ikemoto T, Sakata S, Maegawa H, Kashiwagi A): Azole compounds and medicinal use thereof. WO-03048140 (2003).


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.